MetLife (MET) Shares Sold by SPF Beheer BV
SPF Beheer BV trimmed its holdings in shares of MetLife (NYSE:MET) by 2.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,308,072 shares of the financial services provider’s stock after selling 26,842 shares during the period. MetLife makes up 2.7% of SPF Beheer BV’s investment portfolio, making the stock its 26th largest holding. SPF Beheer BV’s holdings in MetLife were worth $66,136,000 as of its most recent SEC filing.
Other institutional investors have also bought and sold shares of the company. QUANTRES ASSET MANAGEMENT Ltd acquired a new position in shares of MetLife during the fourth quarter worth approximately $1,279,000. CHURCHILL MANAGEMENT Corp raised its position in shares of MetLife by 35.8% during the fourth quarter. CHURCHILL MANAGEMENT Corp now owns 28,309 shares of the financial services provider’s stock worth $1,431,000 after purchasing an additional 7,470 shares during the period. Norinchukin Bank The raised its position in shares of MetLife by 12.9% during the third quarter. Norinchukin Bank The now owns 48,172 shares of the financial services provider’s stock worth $2,503,000 after purchasing an additional 5,505 shares during the period. Carret Asset Management LLC raised its position in shares of MetLife by 3.7% during the third quarter. Carret Asset Management LLC now owns 117,611 shares of the financial services provider’s stock worth $6,110,000 after purchasing an additional 4,159 shares during the period. Finally, BTC Capital Management Inc. raised its position in shares of MetLife by 8.7% during the fourth quarter. BTC Capital Management Inc. now owns 67,833 shares of the financial services provider’s stock worth $3,429,000 after purchasing an additional 5,430 shares during the period. Hedge funds and other institutional investors own 77.64% of the company’s stock.
A number of brokerages have recently weighed in on MET. UBS reaffirmed a “neutral” rating and set a $51.00 target price (down from $52.00) on shares of MetLife in a research report on Friday, March 2nd. Morgan Stanley lowered their target price on MetLife from $59.00 to $58.00 and set an “equal weight” rating on the stock in a research report on Wednesday, February 14th. Wells Fargo set a $60.00 target price on MetLife and gave the stock a “buy” rating in a research report on Tuesday, February 13th. Goldman Sachs reaffirmed a “buy” rating on shares of MetLife in a research report on Wednesday, January 31st. Finally, Keefe, Bruyette & Woods reaffirmed a “buy” rating and set a $56.00 target price on shares of MetLife in a research report on Friday, February 23rd. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. The company has an average rating of “Hold” and an average price target of $57.90.
MetLife (NYSE:MET) last released its quarterly earnings results on Tuesday, February 13th. The financial services provider reported $0.64 EPS for the quarter, missing analysts’ consensus estimates of $1.05 by ($0.41). The company had revenue of $15.79 billion during the quarter, compared to analysts’ expectations of $15.89 billion. MetLife had a net margin of 5.69% and a return on equity of 8.59%. During the same period in the previous year, the company posted $1.28 earnings per share. equities analysts anticipate that MetLife will post 4.93 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 13th. Investors of record on Monday, February 5th were given a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 3.44%. The ex-dividend date was Friday, February 2nd. MetLife’s payout ratio is currently 46.92%.
MetLife, Inc, through its subsidiaries, engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife (NYSE:MET).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.